Intelligent Bio Solutions Inc
NASDAQ:INBS
Cash Flow Statement
Cash Flow Statement
Intelligent Bio Solutions Inc
| Jun-2018 | Sep-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Jun-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Net Income |
(5)
|
(7)
|
(6)
|
(7)
|
(6)
|
(3)
|
(5)
|
(9)
|
(7)
|
(8)
|
(9)
|
(7)
|
(8)
|
(8)
|
(5)
|
(10)
|
(11)
|
(12)
|
(13)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(11)
|
(11)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
(1)
|
3
|
2
|
3
|
4
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Cash Interest Paid |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
1
|
2
|
2
|
1
|
3
|
0
|
(2)
|
(5)
|
(3)
|
(3)
|
2
|
2
|
1
|
(0)
|
(2)
|
0
|
1
|
1
|
2
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(5)
N/A
|
(6)
-7%
|
(4)
+33%
|
(6)
-43%
|
(5)
+7%
|
(0)
+90%
|
(4)
-691%
|
(10)
-156%
|
(11)
-12%
|
(11)
+1%
|
(9)
+18%
|
(3)
+64%
|
(3)
-1%
|
(5)
-59%
|
(6)
-18%
|
(9)
-35%
|
(7)
+13%
|
(7)
+8%
|
(7)
-7%
|
(7)
+1%
|
(10)
-33%
|
(11)
-11%
|
(10)
+5%
|
(10)
-3%
|
(10)
+7%
|
(10)
-5%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(1)
-397%
|
(1)
-54%
|
(2)
-16%
|
(1)
+22%
|
(1)
+43%
|
(0)
+68%
|
(0)
+71%
|
(0)
-265%
|
(0)
+6%
|
0
N/A
|
(0)
N/A
|
(0)
-10%
|
(0)
-22%
|
(0)
-30%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Common Stock |
9
|
9
|
3
|
6
|
6
|
1
|
25
|
26
|
25
|
25
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
0
|
7
|
4
|
5
|
5
|
2
|
6
|
5
|
8
|
|
| Net Issuance of Debt |
1
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(5)
|
(5)
|
(1)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
0
|
(1)
|
11
|
9
|
0
|
10
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
5
0%
|
2
-55%
|
5
+128%
|
6
+10%
|
1
-87%
|
23
+3 048%
|
24
+2%
|
23
-1%
|
23
N/A
|
0
-98%
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
1
N/A
|
1
+3%
|
0
N/A
|
6
N/A
|
15
+163%
|
15
0%
|
15
+0%
|
11
-22%
|
4
-65%
|
5
+15%
|
8
+76%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
0
N/A
|
(0)
N/A
|
(1)
-2 099%
|
(0)
+77%
|
1
N/A
|
0
-67%
|
19
+8 254%
|
14
-29%
|
12
-10%
|
12
+0%
|
(9)
N/A
|
(4)
+60%
|
(4)
-24%
|
(7)
-58%
|
(8)
-21%
|
(8)
-2%
|
(7)
+21%
|
(6)
+17%
|
(2)
+68%
|
7
N/A
|
5
-33%
|
4
-20%
|
1
-70%
|
(7)
N/A
|
(5)
+20%
|
(2)
+56%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(6)
-7%
|
(4)
+33%
|
(6)
-43%
|
(5)
+7%
|
(0)
+90%
|
(4)
-691%
|
(10)
-156%
|
(11)
-12%
|
(11)
+1%
|
(9)
+18%
|
(3)
+64%
|
(3)
-1%
|
(5)
-59%
|
(6)
-18%
|
(9)
-35%
|
(7)
+13%
|
(7)
+8%
|
(7)
-7%
|
(7)
+1%
|
(10)
-33%
|
(11)
-11%
|
(10)
+5%
|
(10)
-3%
|
(10)
+5%
|
(10)
-5%
|
|